In melanoma, it has been found that intravenous injection of a plasmid encoding the extracellular domain of PD-1 can block the PD-1/PD-L1 signaling pathway and inhibit the lung metastasis and drug resistance of tumor cells (68). This evidence concerns the gene PDCD1 and melanoma.